Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-100851

Chief Technical Officer sold 14,437 shares at an average $112.03 ($1,617,337)

  • Chief Technical Officer acquired 14,437 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shulman Joseph Chief Technical Officer 2025-10-16 Option exercise 10b5-1 +2,093 $27.35 $57,244 10,602 D
Shulman Joseph Chief Technical Officer 2025-10-16 Option exercise 10b5-1 +12,344 $30.66 $378,467 22,946 D
Shulman Joseph Chief Technical Officer 2025-10-16 Sale 10b5-1 −2,693 $110.95 $298,784 20,253 D
Shulman Joseph Chief Technical Officer 2025-10-16 Sale 10b5-1 −8,332 $112.06 $933,646 11,921 D
Shulman Joseph Chief Technical Officer 2025-10-16 Sale 10b5-1 −3,412 $112.81 $384,908 8,509 D
Derivatives
Shulman Joseph Chief Technical Officer 2025-10-16 Option exercise · Stock Options (Right to Buy) 10b5-1 −2,093 14,657 D
Shulman Joseph Chief Technical Officer 2025-10-16 Option exercise · Stock Options (Right to Buy) 10b5-1 −12,344 10,469 D
Open-market sales · 14,437 sh · avg $112.03 · $1,617,337
Loading xslF345X05/tm2529018-1_4seq1.xml…